GeminIQ Website Logo

Viewing PMDI free

Subscribe for full history, 90+ metrics, screener, watchlist...

PSYCHEMEDICS CORP

PMDI

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
111121245322
Accounts Receivable Net Current
333445444545
Prepaid Expense And Other Assets Current
112112211221
Income Taxes Receivable
000000000133
Assets Current
56667881010111111
Property Plant And Equipm…
Capitalized Computer Software Gross
6---5---5---
Furniture And Fixtures Gross
2---2---2---
Leasehold Improvements Gross
4---4---4---
Property Plant And Equipment Gross
242332734427566
Accumulated Depreciation Depletion And Amortizatio…
-22222224-24232322-2202120
Property Plant And Equipment Net
2---3---5---
Other Assets Noncurrent
011111111111
Deferred Income Tax Assets Net
----00111100
Operating Lease Right Of Use Asset
111222233333
Finance Lease Right Of Use Asset
00--0-------
Assets
81010111214161819202021
Liabilities Current
Accounts Payable Current
011111110111
Accrued Liabilities Current
222233344433
Short Term Bank Loans And Notes Payable
001-0-------
Long Term Debt Current
000000000001
Finance Lease Liability Current
00--0-------
Operating Lease Liability Current
000111111111
Long Term Debt Noncurrent
----00000001
Deferred Income Tax Liabilities Net
-----0----0-
Liabilities Current
344455666655
Operating Lease Liability Noncurrent
011111122223
Finance Lease Liability Noncurrent
00--0-------
Liabilities
344567788999
Stockholders Equity
Preferred Stock Value
00--0---0000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
353636353535353434343434
Treasury Stock Value
-10-10-10-10-10-10-10-10-10-10-10-10
Retained Earnings Accumulated Deficit
-19-19-18-17-17-16-14-13-12-11-10-10
Accumulated Other Comprehensive Income Loss Net Of…
-2-2-2-2-2-2-2-2-2-2-2-2
Stockholders Equity
55667791011121212
Liabilities And Stockholders Equity
81010111214161819202021
Allowance For Doubtful Accounts Receivable Current
000000000000
Preferred Stock Par Or Stated Value Per Share
0.010.0050.005-0.010.0050.0050.0050.010.0050.0050.005
Preferred Stock Shares Authorized
111-11111111
Preferred Stock Shares Issued
000-00000000
Preferred Stock Shares Outstanding
0-0-00000000
Common Stock Par Or Stated Value Per Share
0.010.0050.0050.0050.010.0050.0050.0050.010.0050.0050.005
Common Stock Shares Authorized
505050505050505050505050
Common Stock Shares Issued
776666666666
Shares Outstanding
666666666666
Treasury Stock Common Shares
111111111---
Treasury Stock Shares
--------1111

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2024-15.09%-8.30%-24.53%-2.15%-0.86%-0.43%36.52%-14.94%-7.71%4.52%6.79%0.00%
2023-4.97%-8.77%-0.17%-18.85%-35.45%-51.84%28.07%64.47%38.16%-12.29%-11.95%-23.21%
20221.27%0.78%3.07%-0.80%-0.19%-0.49%-7.02%-20.63%-10.10%2.64%-4.07%-9.90%
2021----------3.62%-5.65%-8.41%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.82
1.59
1.60
1.48
1.45
1.46
1.46
1.65
1.74
1.74
2.06
1.98
Quick Ratio
1.45
1.25
1.20
1.27
1.20
1.18
1.14
1.46
1.54
1.49
1.73
1.78
Working Capital
2.23M
2.25M
2.26M
2.00M
2.10M
2.49M
2.59M
3.75M
4.25M
4.55M
5.61M
5.20M
Leverage & Debt
Debt to Equity
0.62
0.81
0.76
0.78
0.85
0.90
0.80
0.76
0.74
0.75
0.71
0.68
Debt Ratio
0.38
0.45
0.43
0.44
0.46
0.47
0.44
0.43
0.42
0.43
0.42
0.41
Efficiency & Turnover
Asset Turnover TTM
1.91
1.69
1.57
1.49
1.42
1.32
1.28
1.27
1.25
1.18
1.16
1.13
Days Sales Outstanding TTM
57.36
71.36
61.97
67.11
61.33
76.42
64.96
65.03
56.80
67.69
58.50
61.94
Receivables Turnover TTM
6.36
5.12
5.89
5.44
5.95
4.78
5.62
5.61
6.43
5.39
6.24
5.89
Per Share Metrics
Diluted EPS TTM
-0.32
-
-
-
-0.72
-
-
-
-0.19
-
-
-
Free Cash Flow Per Share TTM
0.15
0.08
-0.14
-0.32
-0.29
-0.08
0.50
0.72
0.84
0.54
0.10
0.16
Dividend Per Share TTM
0.00
0.00
0.27
0.41
0.42
0.76
0.55
0.49
0.49
0.17
0.11
0.04
Margin Metrics
Gross Profit Margin TTM
36.07%
38.36%
37.63%
38.57%
38.07%
37.71%
37.44%
36.82%
36.81%
35.54%
38.17%
39.44%
Operating Profit Margin TTM
-9.62%
-14.46%
-16.56%
-13.71%
-13.22%
-10.56%
-7.10%
-6.51%
-4.29%
-6.51%
-1.79%
0.32%
Net Profit Margin TTM
-9.45%
-14.78%
-21.93%
-20.64%
-18.80%
-17.09%
-8.02%
-6.13%
-4.29%
-7.77%
-4.52%
-2.76%
Growth Metrics
Net Revenue Growth (1Y)
-10.92%
-11.16%
-11.98%
-12.18%
-12.45%
-12.20%
-9.62%
-4.33%
1.33%
9.09%
17.13%
31.57%
Net Income Growth (1Y)
-55.20%
-23.15%
140.58%
195.82%
283.21%
93.21%
60.46%
112.55%
63.01%
-588.38%
-17.59%
-80.40%
EPS Growth (1Y)
-56.17%
-24.96%
136.32%
189.65%
275.60%
111.94%
76.74%
134.01%
60.78%
-580.41%
-18.70%
-80.57%
Valuation Metrics
P/E TTM
-7.06
-4.57
-3.10
-3.83
-4.11
-5.89
-13.82
-19.62
-24.87
-19.50
-32.30
-57.58
P/B TTM
2.56
2.51
2.46
2.72
2.56
3.09
2.87
2.91
2.50
3.36
3.20
3.28
P/S TTM
0.67
0.68
0.68
0.79
0.77
1.01
1.11
1.20
1.07
1.51
1.46
1.59
Market Cap
13.14M
13.68M
14.15M
17.09M
17.07M
22.96M
26.18M
29.57M
26.96M
39.33M
38.14M
40.83M
Enterprise Value
11.81M
12.44M
12.87M
15.90M
15.41M
21.97M
24.19M
25.71M
22.81M
36.61M
37.27M
39.79M
Calculated Values
Free Cash Flow TTM
878.00K
493.00K
-810.00K
-1.87M
-1.64M
-483.00K
2.85M
4.12M
4.70M
3.39M
660.00K
987.00K
Net Debt
-1.34M
-1.24M
-1.28M
-1.19M
-1.66M
-991.00K
-1.99M
-3.85M
-4.15M
-2.72M
-876.00K
-1.04M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-12-17Purchase
Owner: Powell, Anderson Capital …
Title: -
Shares: 19,700
Price/Share: $1.87
Value: $36,839.00
Shares Owned: 614,406
Relationship: TenPercentOwner
Ownership: Indirect
2024-12-12Purchase
Owner: Powell, Anderson Capital …
Title: -
Shares: 75,000
Price/Share: $2.67
Value: $200,250.00
Shares Owned: 494,556
Relationship: TenPercentOwner
Ownership: Indirect
2024-12-10Sale
Owner: Kamin, Peter
Title: -
Shares: 320,708
Price/Share: $2.35
Value: $753,663.80
Shares Owned: 1,499,710
Relationship: Director,TenPercentOwner
Ownership: Indirect
2024-12-03Purchase
Owner: Kamin, Peter
Title: -
Shares: 1,409,712
Price/Share: $2.35
Value: $3,312,823.20
Shares Owned: 1,820,418
Relationship: Director,TenPercentOwner
Ownership: Indirect
2023-08-17Sale
Owner: Doucot, Charles M
Title: Executive Vice President
Shares: 12,700
Price/Share: $4.66
Value: $59,182.00
Shares Owned: 23,250
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2024-12-31
5.05%
Inst. Shares: 296,561
Shares Outstanding: 5,867,000
2024-09-30
19.75%
Inst. Shares: 1,163,995
Shares Outstanding: 5,894,000
2024-06-30
19.18%
Inst. Shares: 1,115,551
Shares Outstanding: 5,817,000
2024-03-31
15.13%
Inst. Shares: 878,335
Shares Outstanding: 5,806,000
2023-12-31
16.65%
Inst. Shares: 955,864
Shares Outstanding: 5,740,000

PSYCHEMEDICS CORP (PMDI) — SEC Financial Statements & Analysis

PSYCHEMEDICS CORP (PMDI) is a services-medical laboratories company, incorporated in DE. PSYCHEMEDICS CORP trades on OTC as: PMDI. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), PSYCHEMEDICS CORP reported a -10.92% year-over-year revenue growth, a Gross Profit Margin of 36.07% (TTM), a Debt-to-Equity ratio of 0.62x, a Price-to-Sales (P/S) ratio of 0.67x (TTM), a Price-to-Book (P/B) ratio of 2.56x (TTM), at a market cap of $13.14M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-10.92%
Gross Profit Margin TTM
36.07%
Debt To Equity
0.62x
P/S TTM
0.67x
P/B TTM
2.56x
Market Cap
$13.14M

Data as of 2024-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PSYCHEMEDICS CORP in?

PSYCHEMEDICS CORP (PMDI) operates in the Services-Medical Laboratories industry.

What is PMDI's market cap?

PSYCHEMEDICS CORP (PMDI) has a market capitalization of $13.14M as of 2024-12-31.

What exchange does PMDI trade on?

PSYCHEMEDICS CORP (PMDI) trades on the OTC.

Where is PSYCHEMEDICS CORP incorporated?

PSYCHEMEDICS CORP is incorporated in DE.

Wall Street's data.
Main Street's price.